Home - Olink

Olink. High quality proteomics & unrivaled throughput. Protein biomarker platform with endless possibilities - Understand real-time...

Read Olink.com news digest here: view the latest Olink articles and content updates right away or get to their most visited pages. Olink.com belongs to a large group of moderately popular websites, with around 37K visitors from all over the world monthly. It seems that Olink content is notably popular in USA, as 39.5% of all users (15K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Olink.com and thus you can safely use it. Olink.com is hosted with Microsoft Corporation (United States) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:
  • 1 235

    Visitors daily
  • 2 470

    Pageviews daily
  • 6

    Google PR
  • 430 942

    Alexa rank

Olink.com news digest

  • 1 year

    Mechanism of Action of an SGLT2 Inhibitor

    Highlighted publication: Zannad F, Ferreira JP, Butler J, Filippatos G, Januzzi JL, Sumin M, Zwick M, Saadati M, Pocock SJ, Sattar N, Anker SD, Packer M. Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the...

  • 1 year

    Olink Flex with Katarina Hornaeus

    All about Olink Flex: https://olink.com/flex
    Olink Insight (where you can build a 21-plex Olink Flex panel from 200 proteins): https://insight.olink.com
    Sweden’s Science for Life laboratory website: https://www.scilifelab.se/about-us/

  • 1 year

    LIF - A Predictor of Immunotherapy Resistance

    Primary reference:
    Loriot Y and Italiano A et al. Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance. Ann Oncol. (2021) 32(11):1381-1390. doi:10.1016/j.annonc.2021.08.1748...

  • 1 year

    A Biomarker of Hereditary Transthyretin-Mediated Amyloidosis

    Primary reference:
    Ticau S and Nioi P et al. (2021) Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis. Neurology. 96(3):e412-e422. doi:10.1212/WNL.0000000000011090
    Information about the APOLLO clinical trial: “APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis” Link to NCT01960348 at the US National Library of Medicine’s Clinical Trials...

Domain history

Web host: Microsoft Corporation
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrant: Not Disclosed
Updated: September 30, 2022
Expires: November 10, 2024
Created: November 11, 1998

Whois record

Safety scores

Trustworthiness

N/A

Child safety

N/A